According to Astellas Pharma's latest financial reports the company's current EPS (TTM) is $0.86. a decrease over its 2021 EPS that were of $0.59.
Year | EPS | Change |
---|---|---|
2022 | $0.55 | -6.61% |
2021 | $0.59 | -38.94% |
2020 | $0.96 | -6.99% |
2019 | $1.04 | 35.86% |
2018 | $0.76 | -17.76% |
2017 | $0.93 | 16.14% |
2016 | $0.80 | 55.87% |
2015 | $0.51 | 62.93% |
2014 | $0.31 | -17.81% |
2013 | $0.38 | -6.39% |
2012 | $0.41 | 16.02% |
2011 | $0.35 | -37.08% |
2010 | $0.56 | -22.19% |
2009 | $0.72 | 5.08% |
2008 | $0.68 | 73.22% |
2007 | $0.40 | 28.89% |
2006 | $0.31 | 76.4% |
2005 | $0.17 | -23.49% |
2004 | $0.23 |